Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Vaccine competition?

<< Previous

Bullboard Posts

Next >>

Comment by Mongoose1975on Feb 12, 2022 12:18pm

447 Views

Post# 34423264

RE:Vaccine competition?

I'm no scientist, but l still think ours is better. The one in the article seems very similar to the MrNA s out there. It trains the body to help crack the protein spike to help our immune system fight off the virus with different degrees of success. Where as ours deactivates the virus altogether 99.9 percent, leaving the spike protein intact allowing our bodies to come up with an immunity to those. Of course, ours is in the earlier stages of clinical tests on mice but seems more promising.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec